Thomas Eugene Shenk (born 1947) is an American virologist. He is currently Emeritus Professor of Life Sciences in the Department of Molecular Biology at Princeton University .
10-428: Shenk is a surname. Notable people with the surname include: Thomas Shenk , professor of Molecular Biology at Princeton University Henry Shenk , American football coach David Shenk , American writer, lecturer, and filmmaker See also [ edit ] Schenck Schenk Shank (disambiguation) [REDACTED] Surname list This page lists people with
20-456: A director at biotech companies, including Novalon Pharmaceutical Corp. (1996-2000), Cell Genesys, Inc. (2001–09), CV Therapeutics, Inc. (2005-2009), Vical, Inc. (2015-2019) and MeiraGTx, Ltd (2015-); and he served on the board of directors of the pharmaceutical company, Merck and Co. (2001–12). Shenk cofounded several biotech companies, most recently Evrys Bio, LLC, that is developing sirtuin 2 modulators as broad-spectrum antivirals, where he chairs
30-518: Is different from Wikidata All set index articles Thomas Shenk Shenk received a BS in biology from the University of Detroit , and earned a Ph.D. in Microbiology under the mentorship of Victor Stollar from Rutgers University . He then trained as a postdoctoral fellow with Paul Berg at Stanford University School of Medicine. He was Assistant Professor of Microbiology at
40-407: The surname Shenk . If an internal link intending to refer to a specific person led you to this page, you may wish to change that link by adding the person's given name (s) to the link. Retrieved from " https://en.wikipedia.org/w/index.php?title=Shenk&oldid=1012600514 " Category : Surnames Hidden categories: Articles with short description Short description
50-731: The Journal of Virology (1994-2002) and as Chair of the American Society for Microbiology Publications Board (2008–17). He has also served on not-for-profit boards including the Fox Chase Cancer Center (2009–15) the Hepatitis B Foundation (2012-) and the Blumberg Institute (2015-). In addition to academia, Shenk has pursued interests in the biotechnology and pharmaceutical industries. He has served as
60-756: The Princeton University Program in Global Health and Health Policy (2008–15). Shenk was named an American Cancer Society Research Professor (1986-), and was appointed an Investigator of the Howard Hughes Medical Institute (1989–99) during his years at Princeton. Shenk is a virologist whose work has focused on the DNA tumor virus, adenovirus, and the herpesvirus, human cytomegalovirus. In the adenovirus system, he developed technologies for introducing mutations into
70-637: The University of Connecticut Health Science Center (1975–80) and Professor of Microbiology at the State University of New York at Stony Brook (1980–84). In 1984, Shenk moved to Princeton University as the James A. Elkins Jr. Professor of Life Sciences and a founding member of the Department of Molecular Biology. He served as Chair of that department (1996-2004), and as a founding Co-Director of
80-661: The board of managers (2013-); and PMV Pharma, Inc., that is developing therapeutics designed to reactivate defective p53 tumor suppressor proteins, where he serves on the scientific advisory board (2013-). In 2021, Shenk transferred to Emeritus status within the Princeton department of Molecular Biology. Shenk received the Eli Lilly and Company Award in Microbiology and Immunology from the American Society for Microbiology in 1982 for his work on adenovirus gene functions. He
90-487: The viral genome and employed that technology to elucidate the functions of viral genes and their oncogenic impact on the infected cell. For cytomegalovirus he has applied genetic, transcriptomic, metabolomic and proteomic approaches to dissect viral gene functions and their roles during active viral growth and latency. He served as President of the American Society for Virology (1997–98) and the American Society for Microbiology (2003–04). He has also served as Editor-in-Chief of
100-685: Was awarded the Arthur Kornberg and Paul Berg Lifetime Achievement Award in Biomedical Sciences from the Stanford University School of Medicine Alumni Association in 2011. He was elected to fellowship in the American Academy of Microbiology in 1993, membership in the U.S. National Academy of Sciences in 1996, and membership the U.S. National Academy of Medicine in 1996. He was elected a fellow of
#296703